263 related articles for article (PubMed ID: 25505998)
1. Hypochondroplasia, Acanthosis Nigricans, and Insulin Resistance in a Child with FGFR3 Mutation: Is It Just an Association?
Mustafa M; Moghrabi N; Bin-Abbas B
Case Rep Endocrinol; 2014; 2014():840492. PubMed ID: 25505998
[TBL] [Abstract][Full Text] [Related]
2. Mild achondroplasia/hypochondroplasia with acanthosis nigricans, normal development, and a p.Ser348Cys FGFR3 mutation.
Couser NL; Pande CK; Turcott CM; Spector EB; Aylsworth AS; Powell CM
Am J Med Genet A; 2017 Apr; 173(4):1097-1101. PubMed ID: 28181399
[TBL] [Abstract][Full Text] [Related]
3. FGFR3 mutations and the skin: report of a patient with a FGFR3 gene mutation, acanthosis nigricans, hypochondroplasia and hyperinsulinemia and review of the literature.
Blomberg M; Jeppesen EM; Skovby F; Benfeldt E
Dermatology; 2010; 220(4):297-305. PubMed ID: 20453470
[TBL] [Abstract][Full Text] [Related]
4. FGFR3-related condition: a skeletal dysplasia with similarities to thanatophoric dysplasia and SADDAN due to Lys650Met.
Farmakis SG; Shinawi M; Miller-Thomas M; Radmanesh A; Herman TE
Skeletal Radiol; 2015 Mar; 44(3):441-5. PubMed ID: 25119967
[TBL] [Abstract][Full Text] [Related]
5. Acanthosis nigricans and insulin sensitivity in patients with achondroplasia and hypochodroplasia due to FGFR3 mutations.
Alatzoglou KS; Hindmarsh PC; Brain C; Torpiano J; Dattani MT
J Clin Endocrinol Metab; 2009 Oct; 94(10):3959-63. PubMed ID: 19622626
[TBL] [Abstract][Full Text] [Related]
6. The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans.
Vajo Z; Francomano CA; Wilkin DJ
Endocr Rev; 2000 Feb; 21(1):23-39. PubMed ID: 10696568
[TBL] [Abstract][Full Text] [Related]
7. Sixteen years and counting: the current understanding of fibroblast growth factor receptor 3 (FGFR3) signaling in skeletal dysplasias.
Foldynova-Trantirkova S; Wilcox WR; Krejci P
Hum Mutat; 2012 Jan; 33(1):29-41. PubMed ID: 22045636
[TBL] [Abstract][Full Text] [Related]
8. Acanthosis nigricans and hypochondroplasia in a child with a K650Q mutation in FGFR3.
Berk DR; Boente Mdel C; Montanari D; Toloza MG; Primc NB; Prado MI; Bayliss SJ; Pique LM; Schrijver I
Pediatr Dermatol; 2010; 27(6):664-6. PubMed ID: 21510009
[TBL] [Abstract][Full Text] [Related]
9. Acanthosis nigricans in a Japanese boy with hypochondroplasia due to a K650T mutation in
Hirai H; Hamada J; Hasegawa K; Ishii E
Clin Pediatr Endocrinol; 2017; 26(4):223-228. PubMed ID: 29026271
[TBL] [Abstract][Full Text] [Related]
10. Familial acanthosis nigricans due to K650T FGFR3 mutation.
Berk DR; Spector EB; Bayliss SJ
Arch Dermatol; 2007 Sep; 143(9):1153-6. PubMed ID: 17875876
[TBL] [Abstract][Full Text] [Related]
11. Suppression of severe achondroplasia with developmental delay and acanthosis nigricans by the p.Thr651Pro mutation.
Manickam K; Donoghue DJ; Meyer AN; Snyder PJ; Prior TW
Am J Med Genet A; 2014 Jan; 164A(1):243-50. PubMed ID: 24352917
[TBL] [Abstract][Full Text] [Related]
12. Familial acanthosis nigricans with p.K650T FGFR3 mutation.
Fukuchi K; Tatsuno K; Matsushita K; Kubo A; Ito T; Tokura Y
J Dermatol; 2018 Feb; 45(2):207-210. PubMed ID: 29068064
[TBL] [Abstract][Full Text] [Related]
13. Severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN): phenotypic analysis of a new skeletal dysplasia caused by a Lys650Met mutation in fibroblast growth factor receptor 3.
Bellus GA; Bamshad MJ; Przylepa KA; Dorst J; Lee RR; Hurko O; Jabs EW; Curry CJ; Wilcox WR; Lachman RS; Rimoin DL; Francomano CA
Am J Med Genet; 1999 Jul; 85(1):53-65. PubMed ID: 10377013
[TBL] [Abstract][Full Text] [Related]
14. Acanthosis nigricans, hypochondroplasia, and FGFR3 mutations: Findings with five new patients, and a review of the literature.
Muguet Guenot L; Aubert H; Isidor B; Toutain A; Mazereeuw-Hautier J; Collet C; Bourrat E; Denis Musquer M; Barbarot S;
Pediatr Dermatol; 2019 Mar; 36(2):242-246. PubMed ID: 30762251
[TBL] [Abstract][Full Text] [Related]
15. Novel fibroblast growth factor receptor 3 (FGFR3) mutations in bladder cancer previously identified in non-lethal skeletal disorders.
van Rhijn BW; van Tilborg AA; Lurkin I; Bonaventure J; de Vries A; Thiery JP; van der Kwast TH; Zwarthoff EC; Radvanyi F
Eur J Hum Genet; 2002 Dec; 10(12):819-24. PubMed ID: 12461689
[TBL] [Abstract][Full Text] [Related]
16. Familial acanthosis nigricans with the FGFR3 mutation: Differences of pigmentation between male and female patients.
Yasuda M; Morimoto N; Shimizu A; Toyoshima T; Yokoyama Y; Ishikawa O
J Dermatol; 2018 Nov; 45(11):1357-1361. PubMed ID: 30168875
[TBL] [Abstract][Full Text] [Related]
17. Distinct missense mutations of the FGFR3 lys650 codon modulate receptor kinase activation and the severity of the skeletal dysplasia phenotype.
Bellus GA; Spector EB; Speiser PW; Weaver CA; Garber AT; Bryke CR; Israel J; Rosengren SS; Webster MK; Donoghue DJ; Francomano CA
Am J Hum Genet; 2000 Dec; 67(6):1411-21. PubMed ID: 11055896
[TBL] [Abstract][Full Text] [Related]
18. Highly activated Fgfr3 with the K644M mutation causes prolonged survival in severe dwarf mice.
Iwata T; Li CL; Deng CX; Francomano CA
Hum Mol Genet; 2001 Jun; 10(12):1255-64. PubMed ID: 11406607
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans.
Meyers GA; Orlow SJ; Munro IR; Przylepa KA; Jabs EW
Nat Genet; 1995 Dec; 11(4):462-4. PubMed ID: 7493034
[TBL] [Abstract][Full Text] [Related]
20. Hypochondroplasia and Acanthosis nigricans: a new syndrome due to the p.Lys650Thr mutation in the fibroblast growth factor receptor 3 gene?
Castro-Feijóo L; Loidi L; Vidal A; Parajes S; Rosón E; Alvarez A; Cabanas P; Barreiro J; Alonso A; Domínguez F; Pombo M
Eur J Endocrinol; 2008 Sep; 159(3):243-9. PubMed ID: 18583390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
